OSTEX INTERNATIONAL INC /WA/
10-Q, EX-27.1, 2000-08-14
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: OSTEX INTERNATIONAL INC /WA/, 10-Q, EX-10.37, 2000-08-14
Next: INSIGHT ENTERPRISES INC, 10-Q, 2000-08-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                         939,000
<SECURITIES>                                 6,438,000
<RECEIVABLES>                                1,080,000
<ALLOWANCES>                                    55,000
<INVENTORY>                                    341,000
<CURRENT-ASSETS>                             8,887,000
<PP&E>                                       4,811,000
<DEPRECIATION>                               3,103,000
<TOTAL-ASSETS>                              11,194,000
<CURRENT-LIABILITIES>                          597,000
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       125,000
<OTHER-SE>                                  10,472,000
<TOTAL-LIABILITY-AND-EQUITY>                11,194,000
<SALES>                                      2,454,000
<TOTAL-REVENUES>                             2,454,000
<CGS>                                          697,000
<TOTAL-COSTS>                                  697,000
<OTHER-EXPENSES>                             3,193,000
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             189,000
<INCOME-PRETAX>                            (1,247,000)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (1,247,000)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (1,247,000)
<EPS-BASIC>                                     (0.10)
<EPS-DILUTED>                                   (0.10)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission